Kyrle disease. Treatment with topically applied tretinoin.
D000287:Administration, Topical; D000328:Adult; D001706:Biopsy; D007644:Darier Disease / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007633:Keratins / Q000096:biosynthesis; D007641:Keratolytic Agents / Q000627:therapeutic use; D008297:Male; D012008:Recurrence; D012867:Skin / Q000378:metabolism / Q000473:pathology; D014801:Vitamin A / Q000008:administration & dosage* / Q000627:therapeutic use
D007641:Keratolytic Agents; D014801:Vitamin A; D007633:Keratins